학술논문

375PD - Phase I study of the checkpoint kinase 1 inhibitor GDC-0575 in combination with gemcitabine (gem) in patients (pts) with refractory solid tumors
Document Type
Abstract
Source
In Annals of Oncology September 2017 28 Supplement 5:v125-v125
Subject
Language
ISSN
0923-7534